You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 165 No. 10, May 23, 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Review Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (28)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Renal Diseases, Other
 •Review
 •Angiology
 •Computed Tomography
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Theophylline for Prevention of Contrast-Induced Nephropathy

A Systematic Review and Meta-analysis

Sean M. Bagshaw, MD; William A. Ghali, MD, MPH

Arch Intern Med. 2005;165:1087-1093.

Background  Contrast-induced nephropathy (CIN) is an important cause of declines in kidney function and is related to greater morbidity, health care costs, and mortality. Adenosine has been proposed to contribute to the pathophysiological process of CIN. We performed a systematic review and meta-analysis of theophylline, an adenosine antagonist, for the prevention of CIN.

Data Sources  Studies were identified in all languages by search of MEDLINE (1966 through November 2003), EMBASE (1980 through week 44 [November] of 2003), and the Cochrane Controlled Clinical Trials Register (1996 through November 2003) databases and selected conference proceedings.

Study Selection  We searched for randomized controlled trials comparing theophylline vs control in patients receiving radiocontrast media for angiography or computed tomography.

Data Extraction  Our primary outcome measures were the risk of CIN, the difference in serum creatinine levels between theophylline and control groups at 48 hours and need for dialysis.

Data Synthesis  Nine randomized controlled trials involving 585 patients were identified and included for analysis. Theophylline protocols and definitions of CIN varied across studies. There was evidence of heterogeneity of results across trials (Q = 9.77; P = .08); therefore, pooled values require cautious interpretation. The overall pooled odds ratio (OR) using a conservative random-effects model was 0.40 (95% confidence interval [CI], 0.14 to 1.16; P = .09) indicating a trend toward reduction in the incidence of CIN with theophylline use. The pooled estimate for the difference in 48-hour serum creatinine levels between the theophylline and control groups was –0.17 mg/dL (95% CI, –0.28 to –0.06 mg/dL) (–15.2 µmol/L [95% CI, –24.6 to –5.7 µmol/L]) (P = .002), indicating that theophylline may be protective in CIN. The incidence of CIN requiring dialysis was uncommon and reported in only 1 case.

Conclusions  Theophylline may reduce the incidence of CIN with an efficacy that is perhaps comparable to that reported in studies of N-acetylcysteine. However, findings are inconsistent across studies. A large, well-designed trial that incorporates the evaluation of clinically relevant outcomes is required to more adequately assess the role for theophylline in CIN prevention.


Author Affiliations: Department of Critical Care Medicine, Calgary Health Region (Dr Bagshaw), and Departments of Internal Medicine (Dr Ghali) and Community Health Sciences (Drs Bagshaw and Ghali) and Centre for Health and Policy Studies (Dr Ghali), University of Calgary, Calgary, Alberta.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The prevention of acute kidney injury an in-depth narrative review: Part 2: Drugs in the prevention of acute kidney injury
Lameire et al.
NDT Plus 2009;2:1-10.
ABSTRACT | FULL TEXT  

Evaluation and Initial Management of Acute Kidney Injury
Himmelfarb et al.
CJASN 2008;3:962-967.
ABSTRACT | FULL TEXT  

Need for Quality Improvement in Renal Systematic Reviews
Mrkobrada et al.
CJASN 2008;3:1102-1114.
ABSTRACT | FULL TEXT  

Meta-analysis: Effectiveness of Drugs for Preventing Contrast-Induced Nephropathy
Kelly et al.
ANN INTERN MED 2008;148:284-294.
ABSTRACT | FULL TEXT  

Contrast-induced nephropathy
Wong and Irwin
Br J Anaesth 2007;99:474-483.
ABSTRACT | FULL TEXT  

Adenosine and kidney function.
Vallon et al.
Physiol. Rev. 2006;86:901-940.
ABSTRACT | FULL TEXT  

Prophylaxis Strategies for Contrast-Induced Nephropathy
Pannu et al.
JAMA 2006;295:2765-2779.
ABSTRACT | FULL TEXT  

In vitro study of various iodinated contrast media.
Downes et al.
Radiology 2006;239:918-921.
FULL TEXT  

Contrast-Induced Nephropathy: A Clinical and Evidence-Based Approach
Tepel et al.
Circulation 2006;113:1799-1806.
FULL TEXT  

Preventing Nephropathy Induced by Contrast Medium
Barrett and Parfrey
NEJM 2006;354:379-386.
FULL TEXT  

JournalScan
Malik
Heart 2005;91:1118-1120.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.